With experience of conducting clinical trials in South Africa, Kenya, Uganda, Tanzania, Rwanda, Botswana and Zambia, Orphan Reach is a CRO that can fully leverage the benefits of this vast region, including:
• Rapid patient recruitment resulting from large populations in various therapeutic areas (many treatment naive), due to its unique socio-economic mix.
• Large pool of highly trained investigators, compliant with ICH-GCP principles, combined with stringent regulatory standards ensures study data from trials in Africa is a valuable component to FDA submissions.
• Africa offers a highly cost effective solution in comparison to the US and Western Europe.
Our clinical teams are highly experienced in conducting clinical trials across the whole of Africa and consist of pharmacists, nurses, lab and other science graduates and post-graduates in paramedical disciplines. Their therapeutic expertise includes immunology, anti-infectives, respiratory and oncology.
Realise the advantages of the African continent with Orphan Reach.